Your browser doesn't support javascript.
loading
Structural diversity of the SARS-CoV-2 Omicron spike.
Gobeil, Sophie M-C; Henderson, Rory; Stalls, Victoria; Janowska, Katarzyna; Huang, Xiao; May, Aaron; Speakman, Micah; Beaudoin, Esther; Manne, Kartik; Li, Dapeng; Parks, Rob; Barr, Maggie; Deyton, Margaret; Martin, Mitchell; Mansouri, Katayoun; Edwards, Robert J; Eaton, Amanda; Montefiori, David C; Sempowski, Gregory D; Saunders, Kevin O; Wiehe, Kevin; Williams, Wilton; Korber, Bette; Haynes, Barton F; Acharya, Priyamvada.
Afiliación
  • Gobeil SM; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Henderson R; Duke Human Vaccine Institute, Durham, NC 27710, USA; Department of Medicine, Duke University, Durham, NC 27710, USA.
  • Stalls V; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Janowska K; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Huang X; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • May A; Duke Human Vaccine Institute, Durham, NC 27710, USA; Department of Biochemistry, Duke University, Durham, NC 27710, USA.
  • Speakman M; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Beaudoin E; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Manne K; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Li D; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Parks R; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Barr M; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Deyton M; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Martin M; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Mansouri K; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Edwards RJ; Duke Human Vaccine Institute, Durham, NC 27710, USA; Department of Medicine, Duke University, Durham, NC 27710, USA.
  • Eaton A; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Montefiori DC; Duke Human Vaccine Institute, Durham, NC 27710, USA; Department of Surgery, Duke University, Durham, NC 27710, USA.
  • Sempowski GD; Duke Human Vaccine Institute, Durham, NC 27710, USA; Department of Medicine, Duke University, Durham, NC 27710, USA.
  • Saunders KO; Duke Human Vaccine Institute, Durham, NC 27710, USA; Department of Surgery, Duke University, Durham, NC 27710, USA.
  • Wiehe K; Duke Human Vaccine Institute, Durham, NC 27710, USA; Department of Medicine, Duke University, Durham, NC 27710, USA.
  • Williams W; Duke Human Vaccine Institute, Durham, NC 27710, USA; Department of Surgery, Duke University, Durham, NC 27710, USA.
  • Korber B; Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
  • Haynes BF; Duke Human Vaccine Institute, Durham, NC 27710, USA; Department of Medicine, Duke University, Durham, NC 27710, USA; Department of Immunology, Duke University, Durham, NC 27710, USA. Electronic address: barton.haynes@duke.edu.
  • Acharya P; Duke Human Vaccine Institute, Durham, NC 27710, USA; Department of Biochemistry, Duke University, Durham, NC 27710, USA; Department of Surgery, Duke University, Durham, NC 27710, USA. Electronic address: priyamvada.acharya@duke.edu.
Mol Cell ; 82(11): 2050-2068.e6, 2022 06 02.
Article en En | MEDLINE | ID: mdl-35447081
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Mol Cell Asunto de la revista: BIOLOGIA MOLECULAR Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Mol Cell Asunto de la revista: BIOLOGIA MOLECULAR Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos